{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:11:14Z","timestamp":1789096274039,"version":"build-2803163510"},"reference-count":158,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.heliyon.2023.e13853","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T20:42:21Z","timestamp":1676666541000},"page":"e13853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-0168","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10316","key":"10.1016\/j.heliyon.2023.e13853_bib1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"issue":"10335","key":"10.1016\/j.heliyon.2023.e13853_bib2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"issue":"10343","key":"10.1016\/j.heliyon.2023.e13853_bib3","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(22)00941-2","article-title":"Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2","volume":"399","author":"Antonelli","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e13853_bib5","first-page":"8019","article-title":"Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review","volume":"25","author":"Kannan","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13853_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12098-022-04077-4","article-title":"The emergence of omicron: challenging times are here again","volume":"89","author":"Singhal","year":"2022","journal-title":"Indian J. Pediatr."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13853_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1473-3099(22)00410-8","article-title":"Omicron subvariants escape antibodies elicited by vaccination and BA.2.2 infection","volume":"22","author":"Yao","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e13853_bib8","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.cell.2022.06.005","article-title":"Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum","volume":"185","author":"Tuekprakhon","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2206576","article-title":"Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5","volume":"387","author":"Hachmann","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"7931","key":"10.1016\/j.heliyon.2023.e13853_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/d41586-022-03157-x","article-title":"Will there be a COVID winter wave? What scientists say","volume":"610","author":"Callaway","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1473-3099(22)00733-2","article-title":"Omicron sublineage BQ.1.1 resistance to monoclonal antibodies","volume":"23","author":"Arora","year":"2023","journal-title":"Lancet Infect. Dis."},{"issue":"7923","key":"10.1016\/j.heliyon.2023.e13853_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"6603","key":"10.1016\/j.heliyon.2023.e13853_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq1841","article-title":"Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure","volume":"377","author":"Reynolds","year":"2022","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e13853_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/embj.20105114","article-title":"SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells","volume":"39","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"issue":"7902","key":"10.1016\/j.heliyon.2023.e13853_bib15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib16","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1038\/s41467-022-33415-5","article-title":"Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study","volume":"13","author":"Hastie","year":"2022","journal-title":"Nat. Commun."},{"issue":"10323","key":"10.1016\/j.heliyon.2023.e13853_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"issue":"10323","key":"10.1016\/j.heliyon.2023.e13853_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(22)00056-3","article-title":"Omicron severity: milder but not mild","volume":"399","author":"Nealon","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2022.8045","article-title":"Excess mortality in Massachusetts during the delta and omicron waves of COVID-19","volume":"328","author":"Faust","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2023.e13853_bib20","series-title":"SARS-CoV-2 Omicron Variant Is as Deadly as Previous Waves after Adjusting for Vaccinations, Demographics, and Comorbidities, 02","author":"Strasser","year":"2022"},{"issue":"10","key":"10.1016\/j.heliyon.2023.e13853_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28568","article-title":"Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review","volume":"4","author":"Groff","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"6593","key":"10.1016\/j.heliyon.2023.e13853_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.abn4947","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa","volume":"376","author":"Pulliam","year":"2022","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e13853_bib23","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41562-022-01450-3","article-title":"Life expectancy changes since COVID-19","volume":"6","author":"Sch\u00f6ley","year":"2022","journal-title":"Nat. Human Behav."},{"key":"10.1016\/j.heliyon.2023.e13853_bib24","doi-asserted-by":"crossref","first-page":"n2713","DOI":"10.1136\/bmj.n2713","article-title":"Covid-19: pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.heliyon.2023.e13853_bib25","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.3390\/molecules26195795","article-title":"Abida, discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19","volume":"26","author":"Imran","year":"2021","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102329","article-title":"Molnupiravir in COVID-19: a systematic review of literature","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.heliyon.2023.e13853_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105252","article-title":"Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern","volume":"198","author":"Vangeel","year":"2022","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13853_bib28","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1021\/jf000220w","article-title":"Assessing antioxidant and prooxidant activities of phenolic compounds","volume":"48","author":"Fukumoto","year":"2000","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/10408398.2012.708909","article-title":"Phenolic compounds of cereals and their antioxidant capacity","volume":"56","author":"Van Hung","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e13853_bib30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/molecules21101374","article-title":"An overview of plant phenolic compounds and their importance in human nutrition and management of type 2 diabetes","volume":"21","author":"Lin","year":"2016","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acs.jnatprod.8b00435","article-title":"Prenylated phenolic compounds from the leaves of Sabia limoniacea and their antiviral activities against porcine epidemic diarrhea virus","volume":"82","author":"Cho","year":"2019","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/14756366.2012.753591","article-title":"Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia","volume":"29","author":"Kim","year":"2014","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11481-021-10028-1","article-title":"Eugenol, a component of holy basil (tulsi) and common spice clove, inhibits the interaction between SARS-CoV-2 spike S1 and ACE2 to induce therapeutic responses","volume":"16","author":"Paidi","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/1040841X.2017.1295225","article-title":"Antimicrobial activity of eugenol and essential oils containing eugenol: a mechanistic viewpoint","volume":"43","author":"Marchese","year":"2017","journal-title":"Crit. Rev. Microbiol."},{"issue":"D1","key":"10.1016\/j.heliyon.2023.e13853_bib36","doi-asserted-by":"crossref","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","article-title":"HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine","volume":"49","author":"Fang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.heliyon.2023.e13853_bib37","doi-asserted-by":"crossref","first-page":"D1110","DOI":"10.1093\/nar\/gky1021","article-title":"SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping","volume":"47","author":"Wu","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.heliyon.2023.e13853_bib38","doi-asserted-by":"crossref","first-page":"D928","DOI":"10.1093\/nar\/gku1004","article-title":"The toxic exposome database","volume":"43","author":"Wishart","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"6482","key":"10.1016\/j.heliyon.2023.e13853_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"issue":"7816","key":"10.1016\/j.heliyon.2023.e13853_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"W1","key":"10.1016\/j.heliyon.2023.e13853_bib41","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1471-2105-15-293","article-title":"jvenn: an interactive Venn diagram viewer","volume":"15","author":"Bardou","year":"2014","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2023.e13853_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.694834","article-title":"A modern genotoxicity testing paradigm: integration of the high-throughput CometChip\u00ae and the TGx-DDI transcriptomic biomarker in human HepaRG\u2122 cell cultures","volume":"9","author":"Buick","year":"2021","journal-title":"Front. Public Health"},{"issue":"W1","key":"10.1016\/j.heliyon.2023.e13853_bib44","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13853_bib45","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/bioinformatics\/btab711","article-title":"ImmuCellAI-mouse: a tool for comprehensive prediction of mouse immune cell abundance and immune microenvironment depiction","volume":"38","author":"Miao","year":"2022","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.heliyon.2023.e13853_bib46","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41590-020-0762-x","article-title":"Single-cell landscape of immunological responses in patients with COVID-19","volume":"21","author":"Zhang","year":"2020","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib47","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"D1","key":"10.1016\/j.heliyon.2023.e13853_bib48","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","article-title":"PubChem BioAssay: 2017 update","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"7807","key":"10.1016\/j.heliyon.2023.e13853_bib49","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"7819","key":"10.1016\/j.heliyon.2023.e13853_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature"},{"issue":"6582","key":"10.1016\/j.heliyon.2023.e13853_bib51","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.abn7760","article-title":"SARS-CoV-2 Omicron variant: antibody evasion and cryo-EM structure of spike protein-ACE2 complex","volume":"375","author":"Mannar","year":"2022","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.heliyon.2023.e13853_bib52","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.3390\/molecules27134319","article-title":"Anti-inflammatory and anti-rheumatic potential of selective plant compounds by targeting TLR-4\/AP-1 signaling: a comprehensive molecular docking and simulation approaches","volume":"27","author":"Khan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e13853_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104748","article-title":"Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2","volume":"136","author":"Mujwar","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"13","key":"10.1016\/j.heliyon.2023.e13853_bib54","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.3390\/ijms22137001","article-title":"Does the SARS-CoV-2 spike protein receptor binding domain interact effectively with the DPP4 (CD26) receptor? A molecular docking study","volume":"22","author":"Cameron","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.heliyon.2023.e13853_bib55","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.bpj.2021.06.016","article-title":"Small molecule therapeutics to destabilize the ACE2-RBD complex: a molecular dynamics study","volume":"120","author":"Razizadeh","year":"2021","journal-title":"Biophys. J."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e13853_bib56","doi-asserted-by":"crossref","first-page":"932","DOI":"10.6026\/97320630017932","article-title":"Comparative molecular docking and simulation analysis of molnupiravir and remdesivir with SARS-CoV-2 RNA dependent RNA polymerase (RdRp)","volume":"17","author":"Patil","year":"2021","journal-title":"Bioinformation"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1039\/D1ME00124H","article-title":"Thermodynamic and structural insights into the repurposing of drugs that bind to SARS-CoV-2 main protease","volume":"7","author":"Wan","year":"2021","journal-title":"Mol Syst Des Eng"},{"key":"10.1016\/j.heliyon.2023.e13853_bib58","first-page":"1","article-title":"A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2","volume":"26","author":"Priya","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00894-022-05059-1","article-title":"Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study","volume":"28","author":"Shahbazi","year":"2022","journal-title":"J. Mol. Model."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J. Mol. Graph. Model."},{"issue":"40","key":"10.1016\/j.heliyon.2023.e13853_bib61","doi-asserted-by":"crossref","first-page":"13959","DOI":"10.1021\/ja5032776","article-title":"Folding simulations for proteins with diverse topologies are accessible in days with a physics-based force field and implicit solvent","volume":"136","author":"Nguyen","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.heliyon.2023.e13853_bib62","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"19\u201325","author":"Abraham","year":"2015","journal-title":"SoftwareX, Volumes 1-2"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13853_bib63","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e13853_bib64","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib65","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e13853_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004586","article-title":"AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility","volume":"11","author":"Ravindranath","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.heliyon.2023.e13853_bib67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/wcms.1121","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Salomon-Ferrer","year":"2013","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e13853_bib68","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13853_bib69","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"issue":"43","key":"10.1016\/j.heliyon.2023.e13853_bib70","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.heliyon.2023.e13853_bib71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.biophys.28.1.155","article-title":"Molecular dynamics simulations of biomolecules: long-range electrostatic effects","volume":"28","author":"Sagui","year":"1999","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13853_bib72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","article-title":"A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations","volume":"22","author":"Kr\u00e4utler","year":"2001","journal-title":"J. Comput. Chem."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e13853_bib73","doi-asserted-by":"crossref","DOI":"10.1063\/1.2464095","article-title":"Langevin stabilization of molecular-dynamics simulations of polymers by means of quasisymplectic algorithms","volume":"126","author":"Larini","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib74","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","article-title":"Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA","volume":"31","author":"Rastelli","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib76","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1021\/ct3010485","article-title":"Improved generalized born solvent model parameters for protein simulations","volume":"9","author":"Nguyen","year":"2013","journal-title":"J. Chem. Theor. Comput."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib77","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","article-title":"Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)","volume":"20","author":"Weiser","year":"1999","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.heliyon.2023.e13853_bib78","series-title":"pdb-tools: a swiss army knife for molecular structures, F1000Res","author":"Rodrigues","year":"2018"},{"key":"10.1016\/j.heliyon.2023.e13853_bib79","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.heliyon.2023.e13853_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.heliyon.2023.e13853_bib81","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e13853_bib82","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib83","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e13853_bib84","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1111\/bph.14465","article-title":"Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPAR\u03b3 attenuates LPS-mediated lung inflammation","volume":"175","author":"Cho","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e13853_bib85","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41577-020-00491-x","article-title":"Regulation of inflammation by the antioxidant haem oxygenase 1","volume":"21","author":"Campbell","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2023.e13853_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107843","article-title":"Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms","volume":"225","author":"Huang","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib87","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3390\/jcm9040982","article-title":"Master regulator analysis of the SARS-CoV-2\/human interactome","volume":"9","author":"Guzzi","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13853_bib88","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2021.01.004","article-title":"Multi-organ proteomic landscape of COVID-19 autopsies","volume":"184","author":"Nie","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib89","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/15548627.2021.1973339","article-title":"Thrombolysis by PLAT\/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia","volume":"18","author":"Thiebaut","year":"2022","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e13853_bib90","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/ijo.2014.27","article-title":"NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism","volume":"38","author":"Chrysovergis","year":"2014","journal-title":"Int. J. Obes."},{"issue":"6278","key":"10.1016\/j.heliyon.2023.e13853_bib91","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.heliyon.2023.e13853_bib92","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/eurheartj\/ehy169","article-title":"Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease","volume":"39","author":"Helgadottir","year":"2018","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib93","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41392-022-01241-2","article-title":"Enhanced replication of SARS-CoV-2 Omicron BA.2 in human forebrain and midbrain organoids","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"35","key":"10.1016\/j.heliyon.2023.e13853_bib94","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2200960119","article-title":"Morphological, cellular, and molecular basis of brain infection in COVID-19 patients","volume":"119","author":"Crunfli","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13853_bib95","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1177\/00220345940730050601","article-title":"Eugenol triggers different pathobiological effects on human oral mucosal fibroblasts","volume":"73","author":"Jeng","year":"1994","journal-title":"J. Dent. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib96","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/jee\/tow130","article-title":"Essential balm: a strong repellent against foraging and defending red imported fire ants (hymenoptera: formicidae)","volume":"109","author":"Wen","year":"2016","journal-title":"J. Econ. Entomol."},{"key":"10.1016\/j.heliyon.2023.e13853_bib97","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3165159","article-title":"Pleiotropic effects of eugenol: the good, the bad, and the unknown","volume":"2021","author":"Aburel","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2023.e13853_bib98","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2217\/fmb-2018-0333","article-title":"Eugenol and derivatives activity against Mycobacterium tuberculosis, nontuberculous mycobacteria and other bacteria","volume":"14","author":"de Almeida","year":"2019","journal-title":"Future Microbiol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13853_bib99","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1269\/jrr.45.435","article-title":"Eugenol as an in vivo radioprotective agent","volume":"45","author":"Tiku","year":"2004","journal-title":"J. Radiat. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2885.2006.00740.x","article-title":"Pharmacokinetics and anesthetic activity of eugenol in male Sprague-Dawley rats","volume":"29","author":"Guenette","year":"2006","journal-title":"J. Vet. Pharmacol. Therapeut."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13853_bib101","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3390\/molecules22081369","article-title":"Anesthetic agents of plant origin: a review of phytochemicals with anesthetic activity","volume":"22","author":"Tsuchiya","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e13853_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8425643","article-title":"Apoptotic inducement of neuronal cells by aluminium chloride and the neuroprotective effect of eugenol in wistar rats","author":"Mesole","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"18","key":"10.1016\/j.heliyon.2023.e13853_bib103","doi-asserted-by":"crossref","first-page":"22664","DOI":"10.1007\/s11356-020-12139-3","article-title":"Eugenol attenuates TiO2 nanoparticles-induced oxidative damage, biochemical toxicity and DNA damage in Wistar rats: an in vivo study","volume":"28","author":"Wani","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.heliyon.2023.e13853_bib104","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8098135","article-title":"Aspirin eugenol ester reduces H2O2-induced oxidative stress of HUVECs via mitochondria-lysosome Axis","author":"Huang","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2023.e13853_bib105","article-title":"Plasma metabonomics and proteomics studies on the anti-thrombosis mechanism of aspirin eugenol ester in rat tail thrombosis model","volume":"215","author":"Ma","year":"2020","journal-title":"J. Proteonomics"},{"issue":"2010","key":"10.1016\/j.heliyon.2023.e13853_bib106","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-60327-029-8_10","article-title":"Assessment of antioxidant activity of eugenol in vitro and in vivo","volume":"610","author":"Nagababu","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib107","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.3390\/molecules17066290","article-title":"Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells","volume":"17","author":"Jaganathan","year":"2012","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib108","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12906-018-2392-5","article-title":"Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells","volume":"18","author":"Abdullah","year":"2018","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.heliyon.2023.e13853_bib109","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3957262","article-title":"An overview on the anti-inflammatory potential and antioxidant profile of eugenol","author":"Barboza","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2023.e13853_bib110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-319-41342-6_3","article-title":"Eugenol and its role in chronic diseases","volume":"929","author":"Fujisawa","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e13853_bib111","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s00415-021-10406-y","article-title":"Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)","volume":"268","author":"Harapan","year":"2021","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13195-021-00850-3","article-title":"Network medicine links SARS-CoV-2\/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment","volume":"13","author":"Zhou","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"issue":"7868","key":"10.1016\/j.heliyon.2023.e13853_bib113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","article-title":"Dysregulation of brain and choroid plexus cell types in severe COVID-19","volume":"595","author":"Yang","year":"2021","journal-title":"Nature"},{"issue":"7907","key":"10.1016\/j.heliyon.2023.e13853_bib114","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK Biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e13853_bib115","article-title":"SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein [published online ahead of print, 2022 Nov 1]","author":"Albornoz","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e13853_bib116","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e13853_bib117","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-021-01433-3","article-title":"Long COVID in a prospective cohort of home-isolated patients","volume":"27","author":"Blomberg","year":"2021","journal-title":"Nat. Med."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e13853_bib118","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1042\/CS20210735","article-title":"The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease","volume":"135","author":"Avolio","year":"2021","journal-title":"Clin. Sci."},{"key":"10.1016\/j.heliyon.2023.e13853_bib119","first-page":"15","article-title":"Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damage","author":"Kulasinghe","year":"2022","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13853_bib120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.stemcr.2022.01.015","article-title":"A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4","volume":"17","author":"Ma","year":"2022","journal-title":"Stem Cell Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13853_bib121","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib122","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib123","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/heartjnl-2022-321492","article-title":"Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank","volume":"109","author":"Raisi-Estabragh","year":"2022","journal-title":"Heart"},{"issue":"664","key":"10.1016\/j.heliyon.2023.e13853_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq3059","article-title":"SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery","volume":"14","author":"Frere","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2023.e13853_bib125","article-title":"Distinguishing features of Long COVID identified through immune profiling","volume":"10","author":"Klein","year":"2022","journal-title":"medRxiv [Preprint]"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib126","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e13853_bib127","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2468-1253(22)00166-2","article-title":"Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens","volume":"7","author":"Brodin","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010343","article-title":"Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung","volume":"18","author":"Wang","year":"2022","journal-title":"PLoS Pathog."},{"issue":"19","key":"10.1016\/j.heliyon.2023.e13853_bib129","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib130","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/hep.21994","article-title":"Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81","volume":"46","author":"Zeisel","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e13853_bib131","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s42255-020-00324-0","article-title":"HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry","volume":"2","author":"Wei","year":"2020","journal-title":"Nat Metab"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061026","article-title":"Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza A virus activity","volume":"8","author":"Dai","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13853_bib133","first-page":"2317","article-title":"Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis c virus","volume":"33","author":"Mustafa","year":"2020","journal-title":"Pak. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e13853_bib134","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tem.2022.04.011","article-title":"Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses","volume":"33","author":"Lam","year":"2022","journal-title":"Trends Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100208","article-title":"The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses","volume":"63","author":"Saud","year":"2022","journal-title":"J. Lipid Res."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e13853_bib136","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/nsr\/nwaa086","article-title":"Plasma metabolomic and lipidomic alterations associated with COVID-19","volume":"7","author":"Wu","year":"2020","journal-title":"Natl. Sci. Rev."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e13853_bib137","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.heliyon.2023.e13853_bib138","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective","volume":"2015","author":"Adela","year":"2015","journal-title":"J. Diabetes Res."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib139","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang","year":"2020","journal-title":"Cell Metabol."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e13853_bib140","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.cell.2019.07.033","article-title":"GDF15 is an inflammation-induced central mediator of tissue tolerance","volume":"178","author":"Luan","year":"2019","journal-title":"Cell"},{"issue":"7914","key":"10.1016\/j.heliyon.2023.e13853_bib141","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-022-04802-1","article-title":"Inflammasome activation in infected macrophages drives COVID-19 pathology","volume":"606","author":"Sefik","year":"2022","journal-title":"Nature"},{"issue":"7914","key":"10.1016\/j.heliyon.2023.e13853_bib142","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib143","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e13853_bib144","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1002\/ptr.7302","article-title":"Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPAR\u03b3-dependent TLR4\/NLRP3\/Caspase-1 signaling suppression in Caco-2 cell line","volume":"35","author":"Corpetti","year":"2021","journal-title":"Phytother Res."},{"issue":"21","key":"10.1016\/j.heliyon.2023.e13853_bib145","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1016\/j.bmc.2014.08.020","article-title":"Thymol and eugenol derivatives as potential antileishmanial agents","volume":"22","author":"de Morais","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e13853_bib146","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejmech.2017.08.030","article-title":"Eugenol derived immunomodulatory molecules against visceral leishmaniasis","volume":"139","author":"Charan Raja","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e13853_bib147","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11095-019-2629-0","article-title":"The natural product eugenol is an inhibitor of the ebola virus in vitro","volume":"36","author":"Lane","year":"2019","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.heliyon.2023.e13853_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155301","article-title":"Oral administration of eugenol oleate cures experimental visceral leishmaniasis through cytokines abundance","volume":"145","author":"Charan Raja","year":"2021","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e13853_bib149","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168815","article-title":"Resistance of aerosolized bacterial viruses to four germicidal products","volume":"11","author":"Turgeon","year":"2016","journal-title":"PLoS One"},{"issue":"664","key":"10.1016\/j.heliyon.2023.e13853_bib150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo5070","article-title":"SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice","volume":"14","author":"Dinnon","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib151","doi-asserted-by":"crossref","first-page":"190","DOI":"10.23736\/S2724-5985.20.02771-3","article-title":"Quercetin Phytosome\u00ae as a potential candidate for managing COVID-19","volume":"67","author":"DI Pierro","year":"2021","journal-title":"Minerva Gastroenterol."},{"key":"10.1016\/j.heliyon.2023.e13853_bib152","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9371403","article-title":"Effect of 4-Allyl-1-hydroxy-2-methoxybenzene (eugenol) on inflammatory and apoptosis processes in dental pulp fibroblasts","author":"Mart\u00ednez-Herrera","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e13853_bib153","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0009-2797(91)90069-J","article-title":"Metabolism and cytotoxicity of eugenol in isolated rat hepatocytes","volume":"77","author":"Thompson","year":"1991","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e13853_bib154","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0300-483X(02)00194-4","article-title":"Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity","volume":"177","author":"Fujisawa","year":"2002","journal-title":"Toxicology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e13853_bib155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e13853_bib156","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in wuhan, China","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e13853_bib157","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e13853_bib158","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin","year":"2020","journal-title":"Obes. Rev."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023010605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023010605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:49:23Z","timestamp":1776214163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023010605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":158,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405844023010605"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13853","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative network pharmacology and in silico analyses identify the anti-omicron SARS-CoV-2 potential of eugenol","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e13853"}}